Clinical trial
BMS-214662 in Treating Patients With Advanced Solid Tumors
NCT00004877 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00004877 |
|---|---|
| Title | BMS-214662 in Treating Patients With Advanced Solid Tumors |
| Official title | Phase I Study of BMS-214662 Oral Dosing in Patients With Advanced Malignancies |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | BMS-214662 |
| Start date | Jul 1, 1999 |
| Primary completion | Apr 1, 2001 |
| First posted | Jun 4, 2004 |
| Last update posted | Dec 3, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: